Visiting Policy Fellow at the UCL Institute for Innovation & Public Purpose in London. She is a global health and innovation expert, focusing on transforming medical R&D to address priority health needs and ensure equitable access to knowledge and technologies where and when needed, including for epidemic preparedness and response. A Bio-Engineer and Ph.D. from Brussels University (VUB), for over 20 years she has combined scientific research, pharmaceutical R&D, policy analysis and research, and advocacy at Brussels University, Médecins Sans Frontières, Drugs for Neglected Diseases initiative, and Open Society Foundations. She is now an independent researcher and consultant including working with Rt. Hon. Helen Clark and other former members of the Independent Panel for Pandemic Preparedness and Response and with the WHO Council on the Economics of Health for All. She is a member of the WHO Technical Advisory Group on Vaccine Market Information for Access. A recent Rockefeller Bellagio Centre resident, she is also an Honorary Science Fellow at the VUB, and author on over 50 international journal publications including in the Lancet, BMJ, Nature, and Vaccines.
For a reasonably open world
